Paras Jain

Dr. Paras Jain


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2011 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
KSKari A Sweeney
Kari A Sweeney
DDDee N Dao
Dee N Dao
MGMichael F Goldberg
Michael F Goldberg
THTsungda Hsu
Tsungda Hsu
MVManjunatha M Venkataswamy
Manjunatha M Venkataswamy
WJWilliam R. Jacobs
William R. Jacobs

1 July 2014 in mBio
Verified
Journal Article
Open access
PDF file
PJParas Jain
Paras Jain
THTsungda Hsu
Tsungda Hsu
MAMasayoshi Arai
Masayoshi Arai
KBKarolin Biermann
Karolin Biermann
DTDavid S Thaler
David S Thaler
WJWilliam R. Jacobs
William R. Jacobs
Specialized transduction has proven to be useful for generating deletion mutants in most mycobacteria, including virulent Mycobacterium tuberculosis . We have improved this system by developing (i) a single-step strategy for the construction of allelic exchange substrates (AES), (ii) a temperature-sensitive shuttle phasmid with a greater cloning capacity than phAE87, and (iii) bacteriophage-mediated transient expression of site-specific recombinase to precisely excise antibiotic markers. The methods ameliorate rate-limiting steps in strain construction in these difficult-to-manipulate bacteria. The new methods for strain construction were demonstrated to generalize to all classes of genes and chromosomal loci by generating more than 100 targeted single- or multiple-deletion substitutions. These improved methods pave the way for the generation of a complete ordered library of M. tuberculosis null strains, where each strain is deleted for a single defined open reading frame in M. tuberculosis. IMPORTANCE This work reports major advances in the methods of genetics applicable to all mycobacteria, including but not limited to virulent M. tuberculosis , which would facilitate comparative genomics to identify drug targets, genetic validation of proposed pathways, and development of an effective vaccine. This study presents all the new methods developed and the improvements to existing methods in an integrated way. The work presented in this study could increase the pace of mycobacterial genetics significantly and will immediately be of wide use. These new methods are transformative and allow for the undertaking of construction of what has been one of the most fruitful resources in model systems: a comprehensive, ordered library set of the strains, each of which is deleted for a single defined open reading frame.

10 April 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CVCatherine Vilchèze
Catherine Vilchèze
THTravis Hartman
Travis Hartman
BWBrian C. Weinrick
Brian C. Weinrick
PJParas Jain
Paras Jain
TWTorin R. Weisbrod
Torin R. Weisbrod
WJWilliam R. Jacobs
William R. Jacobs
Significance: Tuberculosis (TB) patients would greatly benefit from shorter treatment options. The treatment of drug-susceptible TB, a disease caused by the bacillus Mycobacterium tuberculosis , is a lengthy and strenuous process. This long therapy is because of the ability of a small population of cells to become drug-tolerant. Here, we demonstrate that the addition of small thiols to drug-treated M. tuberculosis prevents the emergence of drug-tolerant but also drug-resistant cells leading to sterilization of the cultures in vitro. The thiols potentiate drug activity by preventing the cells from entering a persister state and shutting down their metabolism while generating an oxidative burst. This dual mechanism of killing could lead to novel approaches to shorten TB chemotherapy.

28 October 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WPWelkin H Pope
Welkin H Pope
CFChristina M Ferreira
Christina M Ferreira
DJDeborah Jacobs-Sera
Deborah Jacobs-Sera
RBRobert C Benjamin
Robert C Benjamin
ADAriangela J Davis
Ariangela J Davis
GHGraham Hatfull
Graham Hatfull
Five newly isolated mycobacteriophages –Angelica, CrimD, Adephagia, Anaya, and Pixie – have similar genomic architectures to mycobacteriophage TM4, a previously characterized phage that is widely used in mycobacterial genetics. The nucleotide sequence similarities warrant grouping these into Cluster K, with subdivision into three subclusters: K1, K2, and K3. Although the overall genome architectures of these phages are similar, TM4 appears to have lost at least two segments of its genome, a central region containing the integration apparatus, and a segment at the right end. This suggests that TM4 is a recent derivative of a temperate parent, resolving a long-standing conundrum about its biology, in that it was reportedly recovered from a lysogenic strain of Mycobacterium avium, but it is not capable of forming lysogens in any mycobacterial host. Like TM4, all of the Cluster K phages infect both fast- and slow-growing mycobacteria, and all of them – with the exception of TM4 – form stable lysogens in both Mycobacterium smegmatis and Mycobacterium tuberculosis; immunity assays show that all five of these phages share the same immune specificity. TM4 infects these lysogens suggesting that it was either derived from a heteroimmune temperate parent or that it has acquired a virulent phenotype. We have also characterized a widely-used conditionally replicating derivative of TM4 and identified mutations conferring the temperature-sensitive phenotype. All of the Cluster K phages contain a series of well conserved 13 bp repeats associated with the translation initiation sites of a subset of the genes; approximately one half of these contain an additional sequence feature composed of imperfectly conserved 17 bp inverted repeats separated by a variable spacer. The K1 phages integrate into the host tmRNA and the Cluster K phages represent potential new tools for the genetics of M. tuberculosis and related species.

2 September 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MPMichael W. Panas
Michael W. Panas
PJParas Jain
Paras Jain
HYHui Yang
Hui Yang
SMShimontini Mitra
Shimontini Mitra
DBDebasis Biswas
Debasis Biswas
WJWilliam R. Jacobs
William R. Jacobs
Significance: A mutant strain of Mycobacterium smegmatis mc 2 155 provided the first plasmid transformation platform for any mycobacteria. It has since been used extensively as a surrogate host to study mycobacterial gene functions in Mycobacterium tuberculosis and Mycobacterium leprae . In this report, we discovered that the efficient plasmid transformation (ept) phenotype of mc 2 155 is caused by a loss-of-function mutation in a gene, namely eptC , which encodes a protein that shares homology with the structural maintenance of chromosomes (SMC) family. While SMCs generally promote DNA segregation to daughter cells, we show that EptC selectively inhibits plasmid segregation and thereby establish a new plasmid restrictive role of this mycobacterial SMC homolog.

2 November 2016 in mBio
Verified
Journal Article
Open access
PDF file
PJParas Jain
Paras Jain
BWBrian C. Weinrick
Brian C. Weinrick
EKEric J Kalivoda
Eric J Kalivoda
HYHui Yang
Hui Yang
VMVanisha Munsamy
Vanisha Munsamy
WJWilliam R. Jacobs
William R. Jacobs
Persisters are the minor subpopulation of bacterial cells that lack alleles conferring resistance to a specific bactericidal antibiotic but can survive otherwise lethal concentrations of that antibiotic. In infections with Mycobacterium tuberculosis , such persisters underlie the need for long-term antibiotic therapy and contribute to treatment failure in tuberculosis cases. Here, we demonstrate the value of d ual- r eporter m ycobacteriophages (Φ 2 DRMs) for characterizing M. tuberculosis persisters. The addition of isoniazid (INH) to exponentially growing M. tuberculosis cells consistently resulted in a 2- to 3-log decrease in CFU within 4 days, and the remaining ≤1% of cells, which survived despite being INH sensitive, were INH-tolerant persisters with a distinct transcriptional profile. We fused the promoters of several genes upregulated in persisters to the red fluorescent protein tdTomato gene in Φ 2 GFP10, a mycobacteriophage constitutively expressing green fluorescent protein (GFP), thus generating Φ 2 DRMs. A population enriched in INH persisters exhibited strong red fluorescence, by microscopy and flow cytometry, using a Φ 2 DRM with tdTomato controlled from the dnaK promoter. Interestingly, we demonstrated that, prior to INH exposure, a population primed for persistence existed in M. tuberculosis cells from both cultures and human sputa and that this population was highly enriched following INH exposure. We conclude that Φ 2 DRMs provide a new tool to identify and quantitate M. tuberculosis persister cells. IMPORTANCE Tuberculosis (TB) is again the leading cause of death from a single infectious disease, having surpassed HIV. The recalcitrance of the TB pandemic is largely due to the ability of the pathogen Mycobacterium tuberculosis to enter a persistent state in which it is less susceptible to antibiotics and immune effectors, necessitating lengthy treatment. It has been difficult to study persister cells, as we have lacked tools to isolate these rare cells. In this article, we describe the development of dual-reporter mycobacteriophages that encode a green fluorescent marker of viability and in which the promoters of genes we have identified as induced in the persister state are fused to a gene encoding a red fluorescent protein. We show that these tools can identify heterogeneity in a cell population that correlates with propensity to survive antibiotic treatment and that the proportions of these subpopulations change in M. tuberculosis cells within human sputum during the course of treatment.